Funding for this research was provided by:
Canadian Insitutes of Health Research (Foundation award)
Heart and Stroke Foundation of Canada (T-000353)
Genome Canada (4530)
Received: 3 December 2017
Accepted: 19 February 2018
First Online: 14 March 2018
Ethics approval and consent to participate
: Clinical data and DNA from family members were obtained with informed consent under a protocol approved by the Western University Institutional Review Board (number 07290E). All subjects provided informed consent to participate.
: The proband provided signed consent for publication.
: RAH has received honoraria for membership on advisory boards and speakers’ bureaus for Aegerion, Amgen, Gemphire, Lilly, Merck, Pfizer, Regeneron, Sanofi and Valeant. LRW and ADM have no disclosures to report.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.